Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IrAE”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Testing effectiveness (Phase 2)Looking for participantsNCT06789601
What this trial is testing

Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

Who this might be right for
MalignancyImmune Related Adverse Events
Brigham and Women's Hospital 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07381634
What this trial is testing

The Safety and Efficacy of Ondansetron in Reducing Immune Checkpoint Inhibitor-Related Toxicities

Who this might be right for
Hepatocellular Carcinoma (HCC)IrAE
First Affiliated Hospital of Wenzhou Medical University 66
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07313202
What this trial is testing

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

Who this might be right for
Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE
Fujian Cancer Hospital 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04305145
What this trial is testing

Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis

Who this might be right for
Melanoma Stage IIIMelanoma Stage IVSkin Cancer Stage III+4 more
Massachusetts General Hospital 42
Not applicableStudy completedNCT05450367
What this trial is testing

Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.

Who this might be right for
Blood Cancer
Assistance Publique - Hôpitaux de Paris 249
Not applicableUnknownNCT06243250
What this trial is testing

Hyperpolarized 13C-MRI and Metabolomics for Immune-related Adverse Events

Who this might be right for
Immune-related Adverse Event
Chang Gung Memorial Hospital 30
Not applicableStudy completedNCT06089967
What this trial is testing

Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy

Who this might be right for
CancerImmune-related Adverse Event
Duke University 30
Not applicableLooking for participantsNCT05799898
What this trial is testing

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors

Who this might be right for
CancerImmune Checkpoint InhibitorCardiovascular Complication+1 more
Institut Mutualiste Montsouris 200
Not applicableNot Yet RecruitingNCT07119190
What this trial is testing

A Perioperative Comprehensive Diagnosis and Treatment System for Lung Cancer in the Era of Neoadjuvant Immunotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Peking University People's Hospital 350
Not applicableLooking for participantsNCT06702566
What this trial is testing

The Effect of Serum Ferritin in irAE

Who this might be right for
Immune-related Adverse EventMalignant Solid TumorsAcute Leukemia+1 more
Tianjin Medical University Cancer Institute and Hospital 1,500
Not applicableStudy completedNCT03948724
What this trial is testing

Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

Who this might be right for
Therapeutic Patient EducationImmune Checkpoint InhibitorsMelanoma+4 more
Institut Cancerologie de l'Ouest 411
Not applicableLooking for participantsNCT03989323
What this trial is testing

A Clinical and Biological Prospective Database of Patients Treated With Anticancer Immunotherapy and Follow up of Their Immune-related Adverse Events irAE

Who this might be right for
Cancer
Hospices Civils de Lyon 2,000
Not applicableLooking for participantsNCT05813418
What this trial is testing

Identification of Predictive Biomarkers for Immune-Related Adverse Events (irAEs) in Patients Undergoing Immune CheckPoint Inhibitors (ICPI) Treatment

Who this might be right for
ImmunotherapyImmune Checkpoint InhibitorsImmune-related Adverse Event+1 more
Centre Hospitalier Universitaire, Amiens 150
Not applicableLooking for participantsNCT06461780
What this trial is testing

Exploring Physical and Psychological Needs and Quality of Life in Patients With Advanced Cancer Receiving Immunotherapy

Who this might be right for
CancerImmunotherapyIrAE+4 more
Taipei Veterans General Hospital, Taiwan 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT06785974
What this trial is testing

Statins to Prevent Immune Checkpoint Inhibitor-induced PRogression of AtherosLerosis

Who this might be right for
AtherosclerosisMelanomaImmune-related Adverse Event
Erasmus Medical Center 140
Not applicableLooking for participantsNCT06635954
What this trial is testing

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

Who this might be right for
CancerImmunotherapyPD-1+2 more
Oxford Biodynamics Inc. 2,000
Not applicableStudy completedNCT05934214
What this trial is testing

EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database

Who this might be right for
CancerImmune-related Adverse EventImmune Checkpoint Inhibitor-Related Myocarditis
Groupe Hospitalier Pitie-Salpetriere 141,630
Not applicableUnknownNCT05530187
What this trial is testing

EPRO-based Model of Care to Manage and Monitoring Symptoms of Cancer Patients Treated With Immune Checkpoint Inhibitors

Who this might be right for
Patient Reported Outcome MeasuresPatient Safety
Manuela Eicher 198
Testing effectiveness (Phase 2)Looking for participantsNCT06278857
What this trial is testing

SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)

Who this might be right for
Endometrial Cancer Stage IMmr DeficiencyEndometrioid Endometrial Adenocarcinoma+1 more
Queensland Centre for Gynaecological Cancer 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07303881
What this trial is testing

Golidocitinib for Refractory Immune-related Hematologic Toxicities of Advanced Lung Cancer

Who this might be right for
IrAEHematologic DisorderLung Cancer (Locally Advanced or Metastatic)
The First Affiliated Hospital of Guangzhou Medical University 16
Load More Results